Stay updated on Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from v3.5.2 to v3.5.3, reflecting a site software/version change rather than a change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-25T18:40:01.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:24:13.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Adrenal cortex carcinoma was added as a lay term for Adrenocortical Carcinoma in the Conditions section.
    Difference
    0.0%
    Check dated 2026-03-27T21:52:33.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T19:36:23.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; the page now shows Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T17:46:06.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.4.2, replacing Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T11:52:46.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.